Clinical Trial Update: Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor [Phase 4]

View source ↗

Summary

Phase 4 study evaluating safety and efficacy of tacrolimus (Prograf) with methotrexate for prevention of graft-versus-host disease in patients receiving periphe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: Graft Versus Host Disease | Phase 4 | Status: COMPLETED